Skip to main content

JPMORGAN CHASE & CO

Position in TRVI — Trevi Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in TRVI

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,366,539
+$523,913 QoQ
Shares Held
73,273
+3.7% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 216 holders
Holding Since
Jun 2020
15 quarters on record
Voting authority Sole 39% Shared 0% None 61%

Common Shares in TRVI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. TRVI ranks #172 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRVI

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,366,539 73,273
2026-03-31 $842,626 70,631
2025-12-31 $744,625 59,475
2025-09-30 $538,157 58,815
2025-06-30 $297,250 54,342
2025-03-31 $399,112 63,452
2024-12-31 $913,253 221,664
2024-09-30 $335,726 100,517
2024-06-30 $93,422 31,350
2024-03-31 $87,845 25,463
2023-12-31 $36,157 26,983
2023-09-30 $58,827 26,985
2023-06-30 $79,285 33,174
2020-09-30 $12 3
2020-06-30 $19 3